Delivery Order SPE2DE24D0013-SPE2D625F3EP6
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based molecular diagnostics manufacturer, on September 3, 2025, with an ultimate completion date of September 10, 2025. This delivery order, designated as XPRSARS-COV2-10, carries no set-aside designation and represents procurement of diagnostic solutions from Cepheid's established portfolio of molecular testing systems. The...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $13.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This delivery order, which carries no set-aside designation, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities and equipment. Cepheid specializes in advanced...
- The U.S. Defense Department's Medical Supply Chain awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a molecular diagnostics manufacturer based in Sunnyvale, California. This award, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents a standard delivery order contract type. The contract enables procurement of Cepheid's diagnostic solutions, which the company supplies across...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $12,040 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 21, 2025, with completion expected by August 28, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award supports the federal government's diagnostic testing capabilities through Cepheid's molecular diagnostic solutions,...
- The Defense Department's Medical Supply Chain has awarded a $24,088.95 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, represents procurement under Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The delivery order designation...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,913.79 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 13, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The contract is structured as a delivery...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3EP6Delivery Order
The Medical Supply Chain, a defense-aligned federal agency, awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPRSARS-COV2-10 and issued on June 20, 2025, carries an ultimate completion date of June 27, 2025, with performance occurring in Sunnyvale, CA. The award includes no set-aside designation and represents a relatively modest procurement within Cepheid's broader federal contract portfolio focused on diagnostic testing and related services. Cepheid specializes in GeneXpert diagnostic systems and molecular reagents for detecting infectious diseases including COVID-19, influenza, and respiratory pathogens. The company maintains significant ongoing relationships with federal healthcare agencies, including the Department of Veterans Affairs and Defense Logistics Agency, through multiple indefinite delivery vehicle contracts valued substantially higher—including a $32.8M VA contract through 2030. This delivery order aligns with Cepheid's established role as a critical supplier of molecular diagnostic capabilities across the federal healthcare system, providing essential testing infrastructure and reagent supplies to support military and federal health missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 6/20/25 |